Amerikanische Gesellschaft für Hirudotherapie

Proteome modifications of the medicinal leech nervous system under bacterial challenge

Proteomics published in Proteomics (2006)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Genomik & ProteomikVergote D et al. · Proteomics, 2006

Abstract

Once considered as lacking intrinsic immune mechanisms, the CNS of vertebrates is now known to be capable of mounting its own innate immune response. Interestingly, while invertebrates have been very useful in the interpretation of general vertebrate innate immunity mechanisms, only scarce data are available on the immune response of nervous tissue within this group. This study provides new data on the innate immune response of medicinal leech Hirudo medicinalis CNS. We identified several spots in 2-D gels of leech CNS proteins that showed specific changes following bacterial challenge, thus demonstrating the ability of the leech nervous system to mount a response to an immune stress. Protein identifications were based on comparison of sequence data with publicly available databases and a recently established leech ESTs database. The broad nature of the identified proteins suggests a clear involvement of cytoskeletal rearrangements, endoplasmic reticulum stress, modulation of synaptic activity and calcium mobilization, all during the first 24 hours of this response. Moreover, several of these proteins are specifically expressed in glial cells, suggesting an important role for glial cells in the immune response of the leech nervous system, similar to what has been observed in vertebrates.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
Indexed MeSH termsAmino Acid SequenceAnimalsElectrophoresis, Gel, Two-DimensionalEscherichia coliLeechesMicrococcus luteusMolecular Sequence DataNervous SystemProtein Processing, Post-TranslationalProteomeSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Zusammenfassung

2-D gel proteomic analysis of medicinal leech CNS proteins under bacterial challenge identifies protein changes involving cytoskeletal rearrangements, ER stress, synaptic activity modulation, and calcium mobilization within 24 hours — many specific to glial cells.

Warum dies für die Hirudotherapie relevant ist

This study investigated the innate immune response of the central nervous system of the medicinal leech Hirudo medicinalis following bacterial challenge, using two-dimensional gel electrophoresis to identify proteome changes involving cytoskeletal rearrangements, endoplasmic reticulum stress, synaptic activity modulation, and calcium mobilization within the first 24 hours. It identified several proteins specifically expressed in glial cells, suggesting parallels with vertebrate CNS innate immunity. While this study uses Hirudo medicinalis, it has no direct relevance to hirudotherapy, leech saliva, or the leech secretome—it examines the leech's own neuroimmune biology as an invertebrate model for understanding innate immunity. The connection to ASH's domain is negligible beyond the organism itself; the study provides no data on therapeutic applications, leech-derived compounds, or clinical use.

Zitation

Proteome modifications of the medicinal leech nervous system under bacterial challenge.

Vergote D et al. · Proteomics, 2006

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 26, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.